BioStable Science and Engineering Announces FDA Clearance of the HAART(TM) 300 Aortic Annuloplasty Device

AUSTIN, Texas--(Healthcare Sales & Marketing Network)--BioStable Science & Engineering, Inc. announced today it has received FDA market clearance for the HAART 300 Aortic Annuloplasty Device, the first commercially available internal annuloplasty device de... Devices, Cardiology, FDA BioStable Science & Engineering, HAART 300, Aortic Annuloplasty, aortic valve
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news